interferon beta-1a

This page shows the latest interferon beta-1a news and features for those working in and with pharma, biotech and healthcare.

Ocrevus off to a flying start as Roche raises 2017 forecasts

The take-up of the drug has been buoyed by trials showing that the drug outperformed Merck KGaA's MS stalwart Rebif (interferon beta-1a) in two relapsing MS phase III

Latest news

Roche sets disruptive price for new MS drug Ocrevus in US

Ocrevus' clinical profile has already caught the attention of MS patients and their doctors, with trials showing that the drug outperformed Merck KGaA's Rebif (interferon beta-1a) in two relapsing
Avelumab costs peg back profit at Merck KGaA

Pfizer-partnered avelumab is central to Merck's plans to revitalise its healthcare business, currently under pressure as top-selling Rebif (interferon beta-1a) - an injectable treatment for multiple sclerosis - tries
FDA delays verdict on Roche's MS drug Ocrevus

Ocrevus is the first investigational medicine with the potential to treat both forms, outperforming Merck KGaA's Rebif (interferon beta-1a) in the two relapsing multiple sclerosis phase III trials and
Merck's pharma unit faces tougher 2017 as fertility boost recedes

2017". That's important because Gonal-f has buoyed Merck's healthcare unit in the face of declining sales for its two biggest products - injectable multiple sclerosis therapy Rebif (interferon ... 1a) and colorectal cancer therapy Erbitux (cetuximab) -
Fertility drugs drive healthcare growth at Merck KGaA

Merck makes the most of its portfolio of mature drugs, and top-seller Rebif (interferon beta-1a) for relapsing-remitting multiple sclerosis held up fairly well despite fierce competition from newer,

More from news
Approximately 1 fully matching, plus 60 partially matching documents found.

Latest Intelligence

Tackling a formidable foe

Formidable foe. “With Rebif (interferon beta-1a), Merck’s legacy MS therapy approved in Europe 20 years ago, one of the innovations is the ability to have auto-injectors and devices

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Medical Writer: Competitive Salary

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior Systematic Review Analyst - Oxford: Negotiable

Medical/ Scientific Director: Salary TBC

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Consumer Health Account Director: Circa £60, 000 Gym and More

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Associate Medical Director: Highly Competitive

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Account Director: £48, 000 - £60, 000

Account Manager / Senior Account Manager: 35, 000-40, 000

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Director, Market Access / HEOR - North-West: Negotiable

Project / Account Manager (Medical Education): Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Senior Medical Writer (Remote Working): Competitive Salary Offered

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Associate Director: £75, 000-90, 000

Senior Account Director development role to Business Director, H...: Excellent package

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Associate Editorial Director – Med Comms – London: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...